Molecular structure and function of the glycine receptor chloride channel

Physiological Reviews

Volumn 84, Issue 4, 2004, Pages 1051-1095

  Lynch, Joseph W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CHLORIDE CHANNEL; GEPHYRIN; GLYCINE RECEPTOR; ION CHANNEL; LIGAND; MUSCLE RELAXANT AGENT; NEUROTRANSMITTER; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALPHA CHAIN; BETA CHAIN; BRAIN STEM; CHEMICAL STRUCTURE; CYTOPLASM; CYTOSKELETON; HUMAN; MYOCLONUS; NERVE CELL; NERVOUS SYSTEM; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REFLEX; REVIEW; SENSORY NERVE CELL; SPINAL CORD; STARTLE EPILEPSY; SYNAPSE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHLORIDE CHANNELS; HUMANS; MOLECULAR STRUCTURE; NEURONS; PROTEIN SUBUNITS; RECEPTORS, GLYCINE;

EID: 4644265039     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00042.2003     Document Type: Review

References (438)

1. Absalom NL, Lewis TM, Kaplan W, Pierce KD, and Schofield PR. Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor. J Biol Chem 278: 50151-50157, 2003.
2. A receptor by the insecticide ivermectin. Eur J Pharmacol 394: 163-170, 2000.
3. - current by ethanol in cultured mouse spinal neurons. J Pharmacol Exp Ther 279: 1116-1122, 1996.
4. Ahmadi S, Kotalla C, Guhring H, Takeshima H, Pahl A, and Zeilhofer HU. Modulation of synaptic transmission by nociceptin/ orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor. Mol Pharmacol 59: 612-618, 2001.
5. Akabas MH. Channel-lining residues in the M3 membrane-spanning segment of the cystic fibrosis transmembrane conductance regulator. Biochemistry 37: 12233-12240, 1998.
6. Akabas MH and Karlin A. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the α-subunit. Biochemistry 34: 12496-12500, 1995.
7. Akabas MH, Kaufmann C, Archdeacon P, and Karlin A. Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit. Neuron 13: 919-927, 1994.
8. Akabas MH, Stauffer DA, Xu M, and Karlin A. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258: 307-310, 1992.
9. Akagi H, Hirai K, and Hishinuma F. Cloning of a glycine receptor subtype expressed in rat brain and spinal cord during a specific period of neuronal development. FEBS Lett 281: 160-166, 1991.
10. Akagi H, Hirai K, and Hishinuma F. Functional properties of strychnine-sensitive glycine receptors expressed in Xenopus oocytes injected with a single mRNA. Neurosci Res 11: 28-40, 1991.
11. A receptors: mechanism and involvement of a residue in the M2 region of the α subunit. J Physiol 532: 673-684, 2001.
12. Ali DW, Drapeau P, and Legendre P. Development of spontaneous glycinergic currents in the Mauthner neuron of the zebrafish embryo. J Neurophysiol 84: 1726-1736, 2000.
13. Altschuler RA, Betz H, Parakkal MH, Reeks KA, and Wenthold RJ. Identification of glycinergic synapses in the cochlear nucleus through immunocytochemical localization of the postsynaptic receptor. Brain Res 369: 316-320, 1986.
14. A receptor needs two homologous domains of the β-subunit for activation by GABA but not by pentobarbital. Nature 366: 565-569, 1993.
15. Andermann F and Andermann E. Startle disorders of man: hyperekplexia, jumping and startle epilepsy. Brain Dev 10: 213-222, 1988.
16. Aprison MH and Werman R. The distribution of glycine in cat spinal cord and roots. Life Sci 4: 2075-2083, 1965.
17. Araki T, Yamano M, Murakami T, Wanaka A, Betz H, and Tohyama M. Localization of glycine receptors in the rat central nervous system: an immunocytochemical analysis using monoclonal antibody. Neuroscience 25: 613-624, 1988.
18. Arias HR. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim Biophys Acta 1376: 173-220, 1998.
19. Arias HR. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors. Neurochem Int 36: 595-645, 2000.
20. 2+ from brain tissue during activity. Nature 308: 734-736, 1984.
21. Auld DS. Zinc coordination sphere in biochemical zinc sites. Biometals 14: 271-313, 2001.
22. Barrantes FJ, Antollini SS, Blanton MP, and Prieto M. Topography of nicotinic acetylcholine receptor membrane-embedded domains. J Biol Chem 275: 37333-37339, 2000.
23. Basbaum AI. Distribution of glycine receptor immunoreactivity in the spinal cord of the rat: cytochemical evidence for a differential glycinergic control of lamina I and V nociceptive neurons. J Comp Neurol 278: 330-336, 1988.
24. Baulieu EE, Robel P, and Schumacher M. Neurosteroids: beginning of the story. Int Rev Neurobiol 46: 1-32, 2001.
25. Beato M, Groot-Kormelink PJ, Colquhoun D, and Sivilotti LG. Openings of the rat recombinant α1 homomeric glycine receptor as a function of the number of agonist molecules bound. J Gen Physiol 119: 443-466, 2002.
26. Becker CM. Disorders of the inhibitory glycine receptor: the spastic mouse. FASEB J 4: 2767-2774, 1990.
27. Becker CM, Hoch W, and Betz H. Glycine receptor heterogeneity in rat spinal cord during postnatal development. EMBO J 7: 3717-3726, 1988.
28. Becker CM, Schmieden V, Tarroni P, Strasser U, and Betz H. Isoform-selective deficit of glycine receptors in the mouse mutant spastic. Neuron 8: 283-289, 1992.
29. Becker L, Hartenstein B, Schenkel J, Kuhse J, Betz H, and Weiher H. Transient neuromotor phenotype in transgenic spastic mice expressing low levels of glycine receptor β-subunit: an animal model of startle disease. Eur J Neurosci 12: 27-32, 2000.
30. A-receptor transmission in transgenic mice. J Neurosci 22: 2505-2512, 2002.
31. Beckstead MJ, Phelan R, and Mihic SJ. Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. J Biol Chem 276: 24959-24964, 2001.
32. Beckstead MJ, Phelan R, Trudell JR, Bianchini MJ, and Mihic SJ. Anesthetic and ethanol effects on spontaneously opening glycine receptor channels. J Neurochem 82: 1343-1351, 2002.
33. A receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57: 1199-1205, 2000.
34. Beg AA and Jorgensen EM. EXP-1 is an excitatory GABA-gated cation channel. Nat Neurosci 6: 1145-1152, 2003.
35. A and glycine receptors. Neurochem Int 34: 447-452, 1999.
36. Belelli I, Pistis I, Peters JA, and Lambert JJ. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci 20: 496-502, 1999.
37. A receptor M2-M3 loop secondary structure and changes in accessibility during channel gating. J Biol Chem 277: 43002-43010, 2002.
38. A receptors. J Neurosci 21: 1127-1136, 2001.
39. Birinyi A, Parker D, Antal M, and Shupliakov O. Zinc co-localizes with GABA and glycine in synapses in the lamprey spinal cord. J Comp Neurol 433: 208-221, 2001.
40. Blanton MP and Cohen JB. Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry 33: 2859-2872, 1994.
41. 3H]diazofluorene. J Biol Chem 273: 8659-8668, 1998.
42. 2+. Mol Pharmacol 46: 1156-1159, 1994.
43. A-receptors at GABAergic synaptic contacts demonstrated by triple immunofluorescence staining. Brain Res 642: 59-69, 1994.
44. A receptor: three residues are required for allosteric coupling. J Neurosci 19: 10213-10220, 1999.
45. Bormann J, Hamill OP, and Sakmann B. Mechanism of anion permeation through channels gated by glycine and γ-aminobutyric acid in mouse cultured spinal neurones. J Physiol 385: 243-286, 1987.
46. Bormann J, Rundstrom N, Betz H, and Langosch D. Residues within transmembrane segment M2 determine chloride conductance of glycine receptor homo- and hetero-oligomers. EMBO J 12: 3729-3737, 1993.
47. Bouzat C, Gumilar F, del Carmen Esandi M, and Sine SM. Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor. Biophys J 82: 1920-1929, 2002.
48. 3H]strychnine to rat brain membranes. J Neurochem 47: 691-696, 1986.
49. - channel in the acrosome reaction initiated by recombinant ZP3. Biol Reprod 66: 91-97, 2002.
50. Breitinger HG and Becker CM. Statistical coassembly of glycine receptor α1 wildtype and the hyperekplexia mutant α1(P250T) in HEK 293 cells: impaired channel function is not dominant in the recombinant system. Neurosci Lett 331: 21-24, 2002.
51. Breitinger HG, Villmann C, Becker K, and Becker CM. Opposing effects of molecular volume and charge at the hyperekplexia site α1(P250) govern glycine receptor activation and desensitization. J Biol Chem 276: 29657-29663, 2001.
52. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, and Sixma TK. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411: 269-276, 2001.
53. Brune W, Weber RG, Saul B, von Knebel Doeberitz M, Grond-Ginsbach C, Kellerman K, Meinck HM, and Becker CM. A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors. Am J Hum Genet 58: 989-997, 1996.
54. Buckwalter MS, Cook SA, Davisson MT, White WF, and Camper SA. A frameshift mutation in the mouse α1 glycine receptor gene (Glra1) results in progressive neurological symptoms and juvenile death. Hum Mol Genet 3: 2025-2030, 1994.
55. Buttner C, Sadtler S, Leyendecker A, Laube B, Griffon N, Betz H, and Schmalzing G. Ubiquitination precedes internalization and proteolytic cleavage of plasma membrane-bound glycine receptors. J Biol Chem 276: 42978-42985, 2001.
56. Campos-Caro A, Sala S, Ballesta JJ, Vicente-Agullo F, Criado M, and Sala F. A single residue in the M2-M3 loop is a major determinant of coupling between binding and gating in neuronal nicotinic receptors. Proc Natl Acad Sci USA 93: 6118-6123, 1996.
57. 1β glycine receptors. J Physiol 539: 495-502, 2002.
58. Cascio M, Shenkel S, Grodzicki RL, Sigworth FJ, and Fox RO. Functional reconstitution and characterization of recombinant human α1-glycine receptors. J Biol Chem 276: 20981-20988, 2001.
59. Celentano JJ, Gibbs TT, and Farb DH. Ethanol potentiates GABA- and glycine-induced chloride currents in chick spinal cord neurons. Brain Res 455: 377-380, 1988.
60. Changeux JP and Edelstein SJ. Allosteric receptors after 30 years. Neuron 21: 959-980, 1998.
61. Charnet P, Labarca C, Leonard RJ, Vogelaar NJ, Czyzyk L, Gouin A, Davidson N, and Lester HA. An open-channel blocker interacts with adjacent turns of α-helices in the nicotinic acetylcholine receptor. Neuron 4: 87-95, 1990.
62. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, and Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415: 793-798, 2002.
63. Chattipakorn SC and McMahon LL. Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices. J Neurophysiol 87: 1515-1525, 2002.
64. Chen Z, Dillon GH, and Huang R. Molecular determinants of proton modulation of glycine receptors. J Biol Chem 279: 876-883, 2004.
65. Chesler M. Regulation and modulation of pH in the brain. Physiol Rev 83: 1183-1221, 2003.
66. 3 antagonists in rat spinal neurones. Br J Pharmacol 118: 2115-2125, 1996.
67. Chesnoy-Marchais D. Mode of action of ICS 205,930, a novel type of potentiator of responses to glycine in rat spinal neurones. Br J Pharmacol 126: 801-809, 1999.
68. Chesnoy-Marchais D. Potentiation of glycine responses by dideoxyforskolin and tamoxifen in rat spinal neurons. Eur J Neurosci 17: 681-691, 2003.
69. Chesnoy-Marchais D and Cathala L. Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons. Eur J Neurosci 13: 2195-2204, 2001.
70. 3 receptor antagonists: insight into selectivity. Eur J Pharmacol 402: 205-213, 2000.
71. Choe S, Stevens CF, and Sullivan JM. Three distinct structural environments of a transmembrane domain in the inwardly rectifying potassium channel ROMK1 defined by perturbation. Proc Natl Acad Sci USA 92: 12046-12049, 1995.
72. Colquhoun D. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125: 924-947, 1998.
73. Corringer PJ, Bertrand S, Galzi JL, Devillers-Thiery A, Changeux JP, and Bertrand D. Mutational analysis of the charge selectivity filter of the α7 nicotinic acetylcholine receptor. Neuron 22: 831-843, 1999.
74. Corringer PJ, Le Novere N, and Changeux JP. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40: 431-458, 2000.
75. Croxen R, Newland C, Beeson D, Oosterhuis H, Chauplannaz G, Vincent A, and Newsom-Davis J. Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 6: 767-774, 1997.
76. Cruz-Martin A, Mercado JL, Rojas LV, McNamee MG, and Lasalde-Dominicci JA. Tryptophan substitutions at lipid-exposed positions of the γ M3 transmembrane domain increase the macroscopic ionic current response of the Torpedo californica nicotinic acetylcholine receptor. J Membr Biol 183: 61-70, 2001.
77. Cui J, Ma YP, Lipton SA, and Pan ZH. Glycine receptors and glycinergic synaptic input at the axon terminals of mammalian retinal rod bipolar cells. J Physiol 553: 895-909, 2003.
78. Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LH, Schaeffer JM, and Arena JP. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371: 707-711, 1994.
79. Curtis DR and Duggan AW. The depression of spinal inhibition by morphine. Agents Actions 1: 14-19, 1969.
80. Curtis DR, Hosli L, and Johnston GA. Inhibition of spinal neurons by glycine. Nature 215: 1502-1503, 1967.
81. Curtis DR, Hosli L, and Johnston GA. A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res 6: 1-18, 1968.
82. Curtis DR, Hosli L, Johnston GA, and Johnston IH. The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res 5: 235-258, 1968.
83. Cymes GD, Grosman C, and Auerbach A. Structure of the transition state of gating in the acetylcholine receptor channel pore: a phi-value analysis. Biochemistry 41: 5548-5555, 2002.
84. Daniels S and Roberts RJ. Post-synaptic inhibitory mechanisms of anaesthesia: glycine receptors. Toxicol Lett 100-101: 71-76, 1998.
85. Davies DL, Trudell JR, Mihic SJ, Crawford DK, and Alkana RL. Ethanol potentiation of glycine receptors expressed in Xenopus oocytes antagonized by increased atmospheric pressure. Alcohol Clin Exp Res 27: 743-755, 2003.
86. 2+. J Biol Chem 278: 712-717, 2003.
87. A receptor. J Pharmacol Exp Ther 295: 1051-1060, 2000.
88. Del Giudice EM, Coppola G, Bellini G, Cirillo G, Scuccimarra G, and Pascotto A. A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia. Eur J Hum Genet 9: 873-876, 2001.
89. De Rosa MJ, Rayes D, Spitzmaul G, and Bouzat C. Nicotinic receptor M3 transmembrane domain: position 8′ contributes to channel gating. Mol Pharmacol 62: 406-414, 2002.
90. De Saint Jan D, David-Watine B, Korn H, and Bregestovski P. Activation of human α1 and α2 homomeric glycine receptors by taurine and GABA. J Physiol 535: 741-755, 2001.
91. Devignot V, Prado de Carvalho L, Bregestovski P, and Goblet C. A novel glycine receptor αZ1 subunit variant in the zebrafish brain. Neuroscience 122: 449-457, 2003.
92. Dibas MI, Gonzales EB, Das P, Bell-Horner CL, and Dillon GH. Identification of a novel residue within the second transmembrane domain that confers use-facilitated block by picrotoxin in glycine α1 receptors. J Biol Chem 277: 9112-9117, 2002.
93. Dieudonne S. Glycinergic synaptic currents in Golgi cells of the rat cerebellum. Proc Natl Acad Sci USA 92: 1441-1445, 1995.
94. Dingledine R, Borges K, Bowie D, and Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 51: 7-61, 1999.
95. Doble A. The pharmacology and mechanism of action of riluzole. Neurology 47: S233-S241, 1996.
96. Doi A, Kishimoto K, and Ishibashi H. Modulation of glycine-induced currents by zinc and other metal cations in neurons acutely dissociated from the dorsal motor nucleus of the vagus of the rat. Brain Res 816: 424-430, 1999.
97. Downie DL, Hall AC, Lieb WR, and Franks NP. Effects of inhalational general anaesthetics on native glycine receptors in rat medullary neurones and recombinant glycine receptors in Xenopus oocytes. Br J Pharmacol 118: 493-502, 1996.
98. Drameh P, Richards F, Cross C, Etya'ale D, and Kassalow J. Ten years of NGDO action against river blindness. Trends Parasitol 18: 378, 2002.
99. Du JL and Yang XL. Glycinergic synaptic transmission to bullfrog retinal bipolar cells is input-specific. Neuroscience 113: 779-784, 2002.
100. Dumoulin A, Triller A, and Dieudonne S. IPSC kinetics at identified GABAergic and mixed GABAergic and glycinergic synapses onto cerebellar Golgi cells. J Neurosci 21: 6045-6057, 2001.
101. Elmslie FV, Hutchings SM, Spencer V, Curtis A, Covanis T, Gardiner RM, and Rees M. Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis. J Med Genet 33: 435-436, 1996.
102. Engblom AC, Carlson BX, Olsen RW, Schousboe A, and Kristiansen U. Point mutation in the first transmembrane region of the beta 2 subunit of the γ-aminobutyric acid type A receptor alters desensitization kinetics of γ-aminobutyric acid- and anesthetic-induced channel gating. J Biol Chem 277: 17438-17447, 2002.
103. Engel SR and Grant KA. Neurosteroids and behavior. Int Rev Neurobiol 46: 321-348, 2001.
104. England PM, Zhang Y, Dougherty DA, and Lester HA. Backbone mutations in transmembrane domains of a ligand-gated ion channel: implications for the mechanism of gating. Cell 96: 89-98, 1999.
105. Enz R and Bormann J. Expression of glycine receptor subunits and gephyrin in single bipolar cells of the rat retina. Vis Neurosci 12: 501-507, 1995.
106. Etter A, Cully DF, Liu KK, Reiss B, Vassilatis DK, Schaeffer JM, and Arena JP. Picrotoxin blockade of invertebrate glutamategated chloride channels: subunit dependence and evidence for binding within the pore. J Neurochem 72: 318-326, 1999.
107. Fatima-Shad K and Barry PH. Anion permeation in GABA- and glycine-gated channels of mammalian cultured hippocampal neurons. Proc R Soc Lond B Biol Sci 253: 69-75, 1993.
108. Ferragamo MJ, Golding NL, and Oertel D. Synaptic inputs to stellate cells in the ventral cochlear nucleus. J Neurophysiol 79: 51-63, 1998.
109. Ffrench-Constant RH, Rocheleau TA, Steichen JC, and Chalmers AE. A point mutation in a Drosophila GABA receptor confers insecticide resistance. Nature 363: 449-451, 1993.
110. Filatov GN and White MM. The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating. Mol Pharmacol 48: 379-384, 1995.
111. Findlay GS, Phelan R, Roberts MT, Homanics GE, Bergeson SE, Lopreato GF, Mihic SJ, Blednov YA, and Harris RA. Glycine receptor knock-in mice and hyperekplexia-like phenotypes: comparisons with the null mutant. J Neurosci 23: 8051-8059, 2003.
112. Findlay GS, Wick MJ, Mascia MP, Wallace D, Miller GW, Harris RA, and Blednov YA. Transgenic expression of a mutant glycine receptor decreases alcohol sensitivity of mice. J Pharmacol Exp Ther 300: 526-534, 2002.
113. A receptor current by zinc and other divalent cations. J Neurosci 18: 2944-2953, 1998.
114. Flint AC, Liu X, and Kriegstein AR. Nonsynaptic glycine receptor activation during early neocortical development. Neuron 20: 43-53, 1998.
115. Florman HM, Arnoult C, Kazam IG, Li C, and O'Toole CM. A perspective on the control of mammalian fertilization by egg-activated ion channels in sperm: a tale of two channels. Biol Reprod 59: 12-16, 1998.
116. Franks NP, Dickinson R, de Sousa SL, Hall AC, and Lieb WR. How does xenon produce anaesthesia? Nature 396: 324, 1998.
117. Franks NP and Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 367: 607-614, 1994.
118. Franks NP and Lieb WR. A serious target for laughing gas. Nat Med 4: 383-384, 1998.
119. Frech MJ, Perez-Leon J, Wassle H, and Backus KH. Characterization of the spontaneous synaptic activity of amacrine cells in the mouse retina. J Neuraphysiol 86: 1632-1643, 2001.
120. Frederickson CJ. Neurobiology of zinc and zinc-containing neurons. Int Rev Neurobiol 31: 145-238, 1989.
121. Friauf E, Hammerschmidt B, and Kirsch J. Development of adult-type inhibitory glycine receptors in the central auditory system of rats. J Comp Neural 385: 117-134, 1997.
122. Froh M, Thurman RG, and Wheeler MD. Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes. Am J Physiol Gastrointest Liver Physiol 283: G856-G863, 2002.
123. Fucile S, De Saint Jan D, David-Watine B, Korn H, and Bregestovski P. Comparison of glycine and GABA actions on the zebrafish homomeric glycine receptor. J Physiol 517: 369-383, 1999.
124. Fucile S, De Saint Jan D, de Carvalho LP, and Bregestovski P. Fast potentiation of glycine receptor channels of intracellular calcium in neurons and transfected cells. Neuron 28: 571-583, 2000.
125. Fujita M, Sato K, Sato M, Inoue T, Kozuka T, and Tohyama M. Regional distribution of the cells expressing glycine receptor beta subunit mRNA in the rat brain. Brain Res 560: 23-37, 1991.
126. Galzi JL, Devillers-Thiery A, Hussy N, Bertrand S, Changeux JP, and Bertrand D. Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature 359: 500-505, 1992.
127. A receptor subunits on Renshaw cells: relationship with presynaptic neurotransmitters and postsynaptic gephyrin clusters. J Comp Neurol 444: 275-289, 2002.
128. Gentet LJ and Clements JD. Binding site stoichiometry and the effects of phosphorylation on human α1 homomeric glycine receptors. J Physiol 544: 97-106, 2002.
129. Giacoia GP and Ryan SG. Hyperekplexia associated with apnea and sudden infant death syndrome. Arch Pediatr Adolesc Med 148: 540-543, 1994.
130. Gisselmann G, Pusch H, Hovemann BT, and Hatt H. Two cDNAs coding for histamine-gated ion channels in D. melanogaster. Nat Neurosci 5: 11-12, 2002.
131. Glusker JP. Structural aspects of metal liganding to functional groups in proteins. Adv Protein Chem 42: 1-76, 1991.
132. Goldinger A, Muller WE, and Wollert U. Inhibition of glycine and GABA receptor binding by several opiate agonists and antagonists. Gen Pharmacol 12: 477-479, 1981.
133. Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter DW, Laube B, and Betz H. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40: 797-806, 2003.
134. Gorne-Tschelnokow U, Strecker A, Kaduk C, Naumann D, and Hucho F. The transmembrane domains of the nicotinic acetylcholine receptor contain α-helical and beta structures. EMBO J 13: 338-341, 1994.
135. Graham BA, Schofield PR, Sah P, and Callister RJ. Altered inhibitory synaptic transmission in superficial dorsal horn neurones in spastic and oscillator mice. J Physiol 551: 905-916, 2003.
136. Greferath U, Brandstatter JH, Wassle H, Kirsch J, Kuhse J, and Grunert U. Differential expression of glycine receptor sub-units in the retina of the rat: a study using immunohistochemistry and in situ hybridization. Vis Neurosci 11: 721-729, 1994.
137. Grenningloh G, Pribilla I, Prior P, Multhaup G, Beyreuther K, Taleb O, and Betz H. Cloning and expression of the 58 kd beta subunit of the inhibitory glycine receptor. Neuron 4: 963-970, 1990.
138. Grenningloh G, Rienitz A, Schmitt B, Methfessel C, Zensen M, Beyreuther K, Gundelfinger ED, and Betz H. The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature 328: 215-220, 1987.
139. 1-glycine receptor channel-opening kinetics in the submillisecond time domain. Biophys J 77: 727-738, 1999.
140. Griffon N, Buttner C, Nicke A, Kuhse J, Schmalzing G, and Betz H. Molecular determinants of glycine receptor subunit assembly. EMBO J 18: 4711-4721, 1999.
141. Grosman C, Salamone FN, Sine SM, and Auerbach A. The extracellular linker of muscle acetylcholine receptor channels is a gating control element. J Gen Physiol 116: 327-340, 2000.
142. Grosman C, Zhou M, and Auerbach A. Mapping the conformational wave of acetylcholine receptor channel gating. Nature 403: 773-776, 2000.
143. Grunert U. Distribution of GABA and glycine receptors on bipolar and ganglion cells in the mammalian retina. Microsc Res Tech 50: 130-140, 2000.
144. Grunert U and Ghosh KK. Midget and parasol ganglion cells of the primate retina express the α1 subunit of the glycine receptor. Vis Neurosci 16: 957-966, 1999.
145. Grunert U and Wassle H. Immunocytochemical localization of glycine receptors in the mammalian retina. J Comp Neurol 335: 523-537, 1993.
146. Grunert U and Wassle H. Glycine receptors in the rod pathway of the macaque monkey retina. Vis Neurosci 13: 101-115, 1996.
147. Gundlach AL, Dodd PR, Grabara CS, Watson WE, Johnston GA, Harper PA, Dennis JA, and Healy PJ. Deficit of spinal cord glycine/strychnine receptors in inherited myoclonus of Poll Hereford calves. Science 241: 1807-1810, 1988.
148. Gundlach AL, Kortz G, Burazin TC, Madigan J, and Higgins RJ. Deficit of inhibitory glycine receptors in spinal cord from Peruvian Pasos: evidence for an equine form of inherited myoclonus. Brain Res 628: 263-270, 1993.
149. 3a receptor from cationic to anionic reveals a conserved feature of the ligand-gated ion channel superfamily. J Biol Chem 276: 10977-10983, 2001.
150. A channel that abolish block by picrotoxin. Receptors Channels 3: 13-20, 1995.
151. Han NL, Haddrill JL, and Lynch JW. Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the β-amino acid agonist, taurine. J Neurochem 79: 636-647, 2001.
152. Han Y and Wu SM. Modulation of glycine receptors in retinal ganglion cells by zinc. Proc Natl Acad Sci USA 96: 3234-3238, 1999.
153. Han Y, Zhang J, and Slaughter MM. Partition of transient and sustained inhibitory glycinergic input to retinal ganglion cells. J Neurosci 17: 3392-3400, 1997.
154. Handford CA, Lynch JW, Baker E, Webb GC, Ford JH, Sutherland GR, and Schofield PR. The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes. Brain Res 35: 211-219, 1996.
155. Harrison NL, Kugler JL, Jones MV, Greenblatt EP, and Pritchett DB. Positive modulation of human γ-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. Mol Pharmacol 44: 628-632, 1993.
156. Hartenstein B, Schenkel J, Kuhse J, Besenbeck B, Kling C, Becker CM, Betz H, and Weiher H. Low level expression of glycine receptor beta subunit transgene is sufficient for phenotype correction in spastic mice. EMBO J 15: 1275-1282, 1996.
157. Harvey RJ, Schmieden V, Von Holst A, Laube B, Rohrer H, and Betz H. Glycine receptors containing the α4 subunit in the embryonic sympathetic nervous system, spinal cord and male genital ridge. Eur J Neurosci 12: 994-1001, 2000.
158. 2+ binding site on the human glycine receptor α1 subunit. J Physiol 520: 53-64, 1999.
159. Haverkamp S, Muller U, Harvey K, Harvey RJ, Betz H, and Wassle H. Diversity of glycine receptors in the mouse retina: localization of the α3 subunit. J Comp Neurol 465: 524-539, 2003.
160. Healy PJ, Harper PA, and Dennis JA. Diagnosis of neuraxial oedema in calves. Aust Vet J 63: 95-96, 1986.
161. Healy PJ, Pierce KD, Dennis JD, Windsor PA, and Schofield PR. Bovine myoclonus: model of human hyperekplexia (startle disease). Movement Disorders 17: 743-747, 2002.
162. Hershenson FM, Prodan KA, Kochman RL, Bloss JL, and Mackerer CR. Synthesis of beta-spiro[pyrrolidinoindolines], their binding to the glycine receptor, and in vivo biological acitivity. J Med Chem 20: 1448-1451, 1977.
163. Hosie AM, Akagi H, Ishida M, and Shinozaki H. Actions of 3-[2-phosphonomethyl[1,1-biphenyl]-3-yl]alanine (PMBA) on cloned glycine receptors. Br J Pharmacol 126: 1230-1236, 1999.
164. Howell GA, Welch MG, and Frederickson CJ. Stimulation-induced uptake and release of zinc in hippocampal slices. Nature 308: 736-738, 1984.
165. Huang RQ and Dillon GH. Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor. Neuropharmacology 39: 2195-2204, 2000.
166. Humeny A, Bonk T, Becker K, Jafari-Boroujerdi M, Stephani U, Reuter K, and Becker CM. A novel recessive hyperekplexia allele GLRA1 (S231R): genotyping by MALDI-TOF mass spectrometry and functional characterisation as a determinant of cellular glycine receptor trafficking. Eur J Hum Genet 10: 188-196, 2002.
167. Ikejima K, Qu W, Stachlewitz RF, and Thurman RG. Kupffer cells contain a glycine-gated chloride channel. Am J Physiol Gastrointest Liver Physiol 272: G1581-G1586, 1997.
168. Imoto K, Busch C, Sakmann B, Mishina M, Konno T, Nakai J, Bujo H, Mori Y, Fukuda K, and Numa S. Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature 335: 645-648, 1988.
169. Imoto K, Methfessel C, Sakmann B, Mishina M, Mori Y, Konno T, Fukuda K, Kurasaki M, Bujo H, Fujita Y, and Numa S. Location of a δ-subunit region determining ion transport through the acetylcholine receptor channel. Nature 324: 670-674, 1986.
170. A receptors. J Biol Chem 278: 49279-49285, 2003.
171. A receptor α1 subunit: implications for modulation by inhaled anesthetics and ion channel structure. Neuropharmacology 43: 669-678, 2002.
172. Jeong HJ, Jang IS, Moorhouse AJ, and Akaike N. Activation of presynaptic
173. - current in rat neurons of ventral tegmental area. Neuropharmacology 44: 493-502, 2003.
174. Jonas P, Bischofberger J, and Sandkuhler J. Corelease of two fast neurotransmitters at a central synapse. Science 281: 419-424, 1998.
175. Jones MV and Westbrook GL. The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci 19: 96-101, 1996.
176. Kalloniatis M and Marc RE. Interplexiform cells of the goldfish retina. J Comp Neurol 297: 340-358, 1990.
177. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294: 1030-1038, 2001.
178. Kane NS, Hirschberg B, Qian S, Hunt D, Thomas B, Brochu R, Ludmerer SW, Zheng Y, Smith M, Arena JP, Cohen CJ, Schmatz D, Warmke J, and Cully DF. Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci USA 97: 13949-13954, 2000.
179. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3: 102-114, 2002.
180. Karlin A and Akabas MH. Substituted-cysteine accessibility method. Methods Enzymol 293: 123-145, 1998.
181. A receptor. Nature 421: 272-275, 2003.
182. Kazuyoshi K. Glycine receptors and glycinergic synaptic transmission in the deep cerebellar nuclei of the rat: a patch-clamp study. J Neurophysiol 90: 3490-3500, 2003.
183. 3 receptors. Nature 424: 321-324, 2003.
184. Kelly D, Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, Bunzendaul H, Bradford B, and Lemasters JJ. L-Glycine: a novel anti-inflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care 6: 229-240, 2003.
185. Keramidas A, Moorhouse AJ, French CR, Schofield PR, and Barry PH. M2 pore mutations convert the glycine receptor channel from being anion- to cation-selective. Biophys J 79: 247-259, 2000.
186. Keramidas A, Moorhouse AJ, Pierce KD, Schofield PR, and Barry PH. Cation-selective mutations in the M2 domain of the inhibitory glycine receptor channel reveal determinants of ion-charge selectivity. J Gen Physiol 119: 393-410, 2002.
187. Kingsmore SF, Giros B, Suh D, Bieniarz M, Caron MG, and Seldin MF. Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat Genet 7: 136-141, 1994.
188. Kirsch J and Betz H. The postsynaptic localization of the glycine receptor-associated protein gephyrin is regulated by the cytoskeleton. J Neurosci 15: 4148-4156, 1995.
189. Kneussel M and Betz H. Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model. Trends Neurosci 23: 429-435, 2000.
190. Kneussel M and Betz H. Receptors, gephyrin and gephyrin-associated proteins: novel insights into the assembly of inhibitory postsynaptic membrane specializations. J Physiol 525: 1-9, 2000.
191. Kneussel M, Hermann A, Kirsch J, and Betz H. Hydrophobic interactions mediate binding of the glycine receptor β-subunit to gephyrin. J Neurochem 72: 1323-1326, 1999.
192. Kondratskaya EL, Lishko PV, Chatterjee SS, and Krishtal OA. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. Neurochem Int 40: 647-653, 2002.
193. Koshland DE Jr, Nemethy G, and Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5: 365-385, 1966.
194. Kotak VC, Korada S, Schwartz IR, and Sanes DH. A developmental shift from GABAergic to glycinergic transmission in the central auditory system. J Neurosci 18: 4646-4655, 1998.
195. A and glycine receptors in the mammalian retina. J Neurosci 16: 2127-2140, 1996.
196. Krasowski MD and Harrison NL. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 55: 1278-1303, 1999.
197. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, and Bertrand D. Ivermectin: a positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53: 283-294, 1998.
198. Krusek J and Zemkova H. Effect of ivermectin on γ-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones. Eur J Pharmacol 259: 121-128, 1994.
199. Kuhse J, Kuryatov A, Maulet Y, Malosio ML, Schmieden V, and Betz H. Alternative splicing generates two isoforms of the α2 subunit of the inhibitory glycine receptor. FEBS Lett 283: 73-77, 1991.
200. Kuhse J, Laube B, Magalei D, and Betz H. Assembly of the inhibitory glycine receptor: identification of amino acid sequence motifs governing subunit stoichiometry. Neuron 11: 1049-1056, 1993.
201. Kuhse J, Schmieden V, and Betz H. Identification and functional expression of a novel ligand binding subunit of the inhibitory glycine receptor. J Biol Chem 265: 22317-22320, 1990.
202. Kuhse J, Schmieden V, and Betz H. A single amino acid exchange alters the pharmacology of neonatal rat glycine receptor subunit. Neuron 5: 867-873, 1990.
203. 2+. J Neurophysiol 76: 227-241, 1996.
204. Kusama T, Wang JB, Spivak CE, and Uhl GR. Mutagenesis of the GABA rho1 receptor alters agonist affinity and channel gating. Neuroreport 5: 1209-1212, 1994.
205. Kwok JB, Raskin S, Morgan G, Antoniuk SA, Bruk I, and Schofield PR. Mutations in the glycine receptor α1 subunit (GLRA1) gene in hereditary hyperekplexia pedigrees: evidence for non-penetrance of mutation Y279C. J Med Genet 38: E17, 2001.
206. Labarca C, Nowak MW, Zhang H, Tang L, Deshpande P, and Lester HA. Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors, Nature 376: 514-516, 1995.
207. A receptors. Int Rev Neurobiol 46: 177-205, 2001.
208. Langosch D, Laube B, Rundstrom N, Schmieden V, Bormann J, and Betz H. Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia. EMBO J 13: 4223-4228, 1994.
209. Langosch D, Thomas L, and Betz H. Conserved quaternary structure of ligand-gated ion channels: the postsynaptic glycine receptor is a pentamer. Proc Natl Acad Sci USA 85: 7394-7398, 1988.
210. Lapunzina P, Sanchez JM, Cabrera M, Moreno A, Delicado A, De Torres ML, Mori AM, Quero J, and Lopez Pajares I. Hyperekplexia (Startle disease): a novel mutation (S270T) in the M2 domain of the GLRA1 gene and a molecular review of the disorder. Mol Diagn 7: 125-128, 2003.
211. 2+: a synergistic interplay between presynaptic P2X2 and postsynaptic glycine receptors. Eur J Neurosci 16: 1025-1036, 2002.
212. 2+ modulation of recombinant human inhibitory glycine receptors. J Physiol 522: 215-230, 2000.
213. Laube B, Kuhse J, Rundstrom N, Kirsch J, Schmieden V, and Betz H. Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors. J Physiol 483: 613-619, 1995.
214. Laube B, Langosch D, Betz H, and Schmieden V. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids. Neuroreport 6: 897-900, 1995.
215. Laube B, Maksay G, Schemm R, and Betz H. Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses? Trends Pharmacol Sci 23: 519-527, 2002.
216. Law RJ, Forrest LR, Ranatunga KM, La Rocca P, Tieleman DP, and Sansom MS. Structure and dynamics of the pore-lining helix of the nicotinic receptor: MD simulations in water, lipid bilayers, and transbilayer bundles. Proteins 39: 47-55, 2000.
217. Legendre P. Pharmacological evidence for two types of postsynaptic glycinergic receptors on the Mauthner cell of 52-h-old zebrafish larvae. J Neurophysiol 77: 2400-2415, 1997.
218. Legendre P. A reluctant gating mode of glycine receptor channels determines the time course of inhibitory miniature synaptic events in zebrafish hindbrain neurons. J Neurosci 18: 2856-2870, 1998.
219. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci 58: 760-793, 2001.
220. Legendre P, Muller E, Badiu CI, Meier J, Vannier C, and Triller A. Desensitization of homomeric α1 glycine receptor increases with receptor density. Mol Pharmacol 62: 817-827, 2002.
221. Leite JF, Amoscato AA, and Cascio M. Coupled proteolytic and mass spectrometry studies indicate a novel topology for the glycine receptor. J Biol Chem 275: 13683-13689, 2000.
222. Leite JF and Cascio M. Probing the topology of the glycine receptor by chemical modification coupled to mass spectrometry. Biochemistry 41: 6140-6148, 2002.
223. Leite JF and Cascio M. Structure of ligand-gated ion channels: critical assessment of biochemical data supports novel topology. Mol Cell Neurosci 17: 777-792, 2001.
224. Leonard RJ, Labarca CG, Charnet P, Davidson N, and Lester HA. Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor. Science 242: 1578-1581, 1988.
225. Lester HA. The permeation pathway of neurotransmitter-gated ion channels. Annu Rev Biophys Biomol Struct 21: 267-292, 1992.
226. Levitan IB. Modulation of ion channels by protein phosphorylation. How the brain works. Adv Second Messenger Phosphoprotein Res 33: 3-22, 1999.
227. Lewis TM, Schofield PR, and McClellan AM. Kinetic determinants of agonist action at the recombinant human glycine receptor. J Physiol 549: 361-374, 2003.
228. Lewis TM, Sivilotti LG, Colquhoun D, Gardiner RM, Schoepfer R, and Rees M. Properties of human glycine receptors containing the hyperekplexia mutation α1(K276E), expressed in Xenopus oocytes. J Physiol 507: 25-40, 1998.
229. A and glycine receptors in rat spinal dorsal horn neurons. J Biol Chem 278: 38637-38645, 2003.
230. Lim R, Alvarez FJ, and Walmsley B. GABA mediates presynaptic inhibition at glycinergic synapses in a rat auditory brainstem nucleus. J Physiol 525: 447-459, 2000.
231. Lin B, Martin PR, Solomon SG, and Grunert U. Distribution of glycine receptor subunits on primate retinal ganglion cells: a quantitative analysis. Eur J Neurosci 12: 4155-4170, 2000.
232. Llanos MN, Ronco AM, Aguirre MC, and Meizel S. Hamster sperm glycine receptor: evidence for its presence and involvement in the acrosome reaction. Mol Reprod Dev 58: 205-215, 2001.
233. Lummis SC, Gundlach AL, Johnston GA, Harper PA, and Dodd PR. Increased γ-aminobutyric acid receptor function in the cerebral cortex of myoclonic calves with an hereditary deficit in glycine/strychnine receptors. J Neurochem 55: 421-426, 1990.
234. Lynch JW, Han NL, Haddrill J, Pierce KD, and Schofield PR. The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state. J Neurosci 21: 2589-2599, 2001.
235. Lynch JW, Jacques P, Pierce KD, and Schofield PR. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways. J Neurochem 71: 2159-2168, 1998.
236. Lynch JW, Rajendra S, Barry PH, and Schofield PR. Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator. J Biol Chem 270: 13799-13806, 1995.
237. Lynch JW, Rajendra S, Pierce KD, Handford CA, Barry PH, and Schofield PR. Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel. EMBO J 16: 110-120, 1997.
238. Machu TK. Colchicine competitively antagonizes glycine receptors expressed in Xenopus oocytes. Neuropharmacology 37: 391-396, 1998.
239. Mackerer CR, Kochman RL, Shen TF, and Hershenson FM. The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord. J Phamacol Exp Ther 201: 326-331, 1977.
240. 3 serotonin receptor ligands. Neuropharmacology 37: 1633-1641, 1998.
241. Maksay G and Biro T. Dual cooperative allosteric modulation of binding to ionotropic glycine receptors. Neuropharmacology 43: 1087-1098, 2002.
242. Maksay G, Laube B, and Betz H. Selective blocking effects of tropisetron and atropine on recombinant glycine receptors. J Neurochem 73: 802-806, 1999.
243. A receptors. Br J Pharmacol 129: 1794-1800, 2000.
244. Malosio ML, Grenningloh G, Kuhse J, Schmieden V, Schmitt B, Prior P, and Betz H. Alternative splicing generates two variants of the α1 subunit of the inhibitory glycine receptor. J Biol Chem 266: 2048-2053, 1991.
245. Malosio ML, Marqueze-Pouey B, Kuhse J, and Betz H. Wide-spread expression of glycine receptor subunit mRNAs in the adult and developing rat brain. EMBO J 10: 2401-2409, 1991.
246. Mangin JM, Baloul M, Prado De Carvalho L, Rogister B, Rigo JM, and Legendre P. Kinetics properties of the α2 homo-oligomeric glycine receptor impairs a proper synaptic functioning. J Physiol 553: 369-386, 2003.
247. Mangin JM, Guyon A, Eugene D, Paupardin-Tritsch D, and Legendre P. Functional glycine receptor maturation in the absence of glycinergic input in dopaminergic neurones of the rat substantia nigra. J Physiol 542: 685-697, 2002.
248. Marchetti C, Pagnotta S, Donato R, and Nistri A. Inhibition of spinal or hypoglossal motoneurons of the newborn rat by glycine or GABA. Eur J Neurosci 15: 975-983, 2002.
249. Marvizon JC, Vazquez J, Garcia Calvo M, Mayor F Jr, Ruiz Gomez A, Valdivieso F, and Benavides J. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites. Mol Pharmacol 30: 590-597, 1986.
250. Mascia MP, Machu TK, and Harris RA. Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br J Pharmacol 119: 1331-1336, 1996.
251. Mascia MP, Mihic SJ, Valenzuela CF, Schofield PR, and Harris RA. A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors. Mol Pharmacol 50: 402-406, 1996.
252. Mascia MP, Trudell JR, and Harris RA. Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. Proc Natl Acad Sci USA 97: 9305-9310, 2000.
253. Mascia MP, Wick MJ, Martinez LD, and Harris RA. Enhancement of glycine receptor function by ethanol: role of phosphorylation. Br J Pharmacol 125: 263-270, 1998.
254. Matzenbach B, Maulet Y, Sefton L, Courtier B, Avner P, Guenet JL, and Betz H. Structural analysis of mouse glycine receptor a subunit genes. Identification and chromosomal localization of a novel variant. J Biol Chem 269: 2607-2612, 1994.
255. Meier H and Chai CK. Spastic, an hereditary neurological mutation in the mouse characterized by vertebral arthropathy and leptomeningeal cyst formation. Exp Med Surg 28: 24-38, 1970.
256. Meier J and Schmieden V. Inhibition of a-subunit glycine receptors by quinoxalines. Neuroreport 14: 1507-1510, 2003.
257. Meizel S. Amino acid neurotransmitter receptor/chloride channels of mammalian sperm and the acrosome reaction. Biol Reprod 56: 569-574, 1997.
258. - channel in porcine sperm. Biochem Biophys Res Commun 223: 675-678, 1996.
259. Meyer G, Kirsch J, Betz H, and Langosch D. Identification of a gephyrin binding motif on the glycine receptor beta subunit. Neuron 15: 563-572, 1995.
260. A and glycine receptor function. Neurochem Int 35: 115-123, 1999.
261. Mihic SJ and Harris RA. Inhibition of rho1 receptor GABAergic currents by alcohols and volatile anesthetics. J Pharmacol Exp Ther 277: 411-416, 1996.
262. A and glycine receptors. Nature 389: 385-389, 1997.
263. Milani N, Dalpra L, del Prete A, Zanini R, and Larizza L. A novel mutation (Gln266→His) in the α1 subunit of the inhibitory glycine-receptor gene (GLRA1) in hereditary hyperekplexia. Am J Hum Genet 58: 420-422, 1996.
264. Milani N, Mulhardt C, Weber RG, Lichter P, Kioschis P, Poustka A, and Becker CM. The human glycine receptor beta subunit gene (GLRB): structure, refined chromosomal localization, and population polymorphism. Genomics 50: 341-345, 1998.
265. Miller C. Genetic manipulation of ion channels: a new approach to structure and mechanism. Neuron 2: 1195-1205, 1989.
266. MAyazawa, A, Fujiyoshi Y, Stowell M, and Unwin N. Nicotinic acetylcholine receptor at 4.6 Å resolution: transverse tunnels in the channel wall. J Mol Biol 288: 765-786, 1999.
267. Miyazawa A, Fujiyoshi Y, and Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 424: 949-955, 2003.
268. 1β glycine receptor channels. Eur Biophys J 32: 529-536, 2003.
269. A and glycine receptor channels. Eur J Pharmacol 415: 135-140, 2001.
270. Monaghan D. Glycine modulation of NMDA receptors: autoradiographic studies. In: Glycine Neurotransmission, edited by Otterson OP and Storm-Mathisen J. New York: Wiley, 1990.
271. Moorhouse AJ, Jacques P, Barry PH, and Schofield PR. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating. Mol Pharmacol 55: 386-395, 1999.
272. Moorhouse AJ, Keramidas A, Zaykin A, Schofield PR, and Barry PH. Single channel analysis of conductance and rectification in cation-selective, mutant glycine receptor channels. J Gen Physiol 119: 411-425, 2002.
273. Mori M, Gahwiler BH, and Gerber U. Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J Physiol 539: 191-200, 2002.
274. A receptors by cAMP-dependent protein phosphorylation. Science 257: 661-665, 1992.
275. Mulhardt C, Fischer M, Gass P, Simon-Chazottes D, Guenet JL, Kuhse J, Betz H, and Becker CM. The spastic mouse: aberrant splicing of glycine receptor beta subunit mRNA caused by intronic insertion of LI element. Neuron 13: 1003-1015, 1994.
276. Nevin ST, Cromer BA, Haddrill JI J, Morton CJ, Parker MW, and Lynch JW. Insights into the structural basis for zinc inhibition of the glycine receptor. J Biol Chem 278: 28985-28992, 2003.
277. Newland CF and Cull-Candy SG. On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. J Physiol 447: 191-213, 1992.
278. Nguyen L, Malgrange B, Belachew S, Rogister B, Rocher V, Moonen G, and Rigo JM. Functional glycine receptors are expressed by postnatal nestin-positive neural stem/progenitor cells. Eur J Neurosci 15: 1299-1305, 2002.
279. Nicoll RA, Malenka RC, and Kauer JA. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol Rev 70: 513-565, 1990.
280. Nikolic Z, Laube B, Weber RG, Lichter P, Kioschis P, Poustka A, Mulhardt C, and Becker CM. The human glycine receptor subunit α3. Glra3 gene structure, chromosomal localization, and functional characterization of alternative transcripts. J Biol Chem 273: 19708-19714, 1998.
281. Nishizaki T and Ikeuchi Y. Activation of endogenous protein kinase C enhances currents through α1 and α2 glycine receptor channels. Brain Res 687: 214-216, 1995.
282. Noh JH, Choi S, Lee JH, Betz H, Kim JI, Park CS, Lee SM, and Nah SY. Effects of ginsenosides on glycine receptor α1 channels expressed in Xenopus oocytes. Mol Cells 15: 34-39, 2003.
283. O'Brien JA and Berger AJ. Cotransmission of GABA and glycine to brain stem motoneurons. J Neurophysiol 82: 1638-1641, 1999.
284. O'Mara M, Barry PH, and Chung SH. A model of the glycine receptor deduced from Brownian dynamics studies. Proc Natl Acad Sci USA 100: 4310-4315, 2003.
285. O'Shea SM and Harrison NL. Arg-274 and Leu-277 of the 7-aminobutyric acid type A receptor α2 subunit define agonist efficacy and potency. J Biol Chem 275: 22764-22768, 2000.
286. Palma E, Fucile S, Barabino B, Miledi R, and Eusebi F. Strychnine activates neuronal α7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains. Proc Natl Acad Sci USA 96: 13421-13426, 1999.
287. A γ2S, glycine α1 and glycine α2 receptor subunits in vitro. Eur J Neurosci 12: 3137-3145, 2000.
288. Panicker S, Cruz H, Arrabit C, and Slesinger PA. Evidence for a centrally located gate in the pore of a serotonin-gated ion channel. J Neurosci 22: 1629-1639, 2002.
289. Pascual JM and Karlin A. State-dependent accessibility and electrostatic potential in the channel of the acetylcholine receptor. Inferences from rates of reaction of thiosulfonates with substituted cysteines in the M2 segment of the α subunit. J Gen Physiol 111: 717-739, 1998.
290. Pawson T. Protein modules and signalling networks. Nature 373: 573-580, 1995.
291. Pfeiffer F and Betz H. Solubilization of the glycine receptor from rat spinal cord. Brain Res 226: 273-279, 1981.
292. Pfeiffer F, Graham D, and Betz H. Purification by affinity chromatography of the glycine receptor of rat spinal cord. J Biol Chem 257: 9389-9393, 1982.
293. Piechotta K, Weth F, Harvey RJ, and Friauf E. Localization of rat glycine receptor α1 and α2 subunit transcripts in the developing auditory brainstem. J Comp Neurol 438: 336-352, 2001.
294. Pierce KD, Handford CA, Morris R, Vafa B, Dennis JA, Healy PJ, and Schofield PR. A nonsense mutation in the α1 subunit of the inhibitory glycine receptor associated with bovine myoclonus. Mol Cell Neurosci 17: 354-363, 2001.
295. A and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Br J Pharmacol 122: 1707-1719, 1997.
296. A receptor channels expressed in Chinese hamster ovary cells: regulation by pentobarbital and picrotoxin. Mol Pharmacol 42: 872-881, 1992.
297. Pourcho RG. Neurotransmitters in the retina. Curr Eye Res 15: 797-803, 1996.
298. Pribilla, I, Takagi T, Langosch D, Bormann J, and Betz H. The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. EMBO J 11: 4305-4311, 1992.
299. Prince RJ and Simmonds MA. Steroid modulation of the strychnine-sensitive glycine receptor. Neuropharmacology 31: 201-205, 1992.
300. Prior P, Schmitt B, Grenningloh G, Pribilla I, Multhaup G, Beyreuther K, Maulet Y, Werner P, Langosch D, Kirsch J, and Betz H. Primary structure and alternative splice variants of gephyrin, a putative glycine receptor-tubulin linker protein. Neuron 8: 1161-1170, 1992.
301. 3H]strychnine. Neuroscience 17: 11-35, 1986.
302. Protti DA, Gerschenfeld HM, and Llano I. GABAergic and glycinergic IPSCs in ganglion cells of rat retinal slices. J Neurosci 17: 6075-6085, 1997.
303. Qian H, Ripps H, Schuette E, and Chappell RL. Responses of small- and large-field bipolar cells to GABA and glycine. Brain Res 893: 273-277, 2001.
304. 2+ due to vasoactive mediators in hepatic parenchymal cells. Am J Physiol Gastrointest Liver Physiol 283: G1249-G1256, 2002.
305. Rajendra S, Lynch JW, Pierce KD, French CR, Barry PH, and Schofield PR. Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonists. Neuron 14: 169-175, 1995.
306. Rajendra S, Lynch JW, Pierce KD, French CR, Barry PH, and Schofield PR. Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor. J Biol Chem 269: 18739-18742, 1994.
307. Rajendra S, Lynch JW, and Schofield PR. The glycine receptor. Pharmacol Ther 73: 121-146, 1997.
308. Rajendra S and Schofield PR. Molecular mechanisms of inherited startle syndromes. Trends Neurosci 18: 80-82, 1995.
309. Rajendra S, Vandenberg RJ, Pierce KD, Cunningham AM, French PW, Barry PH, and Schofield PR. The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element. EMBO J 14: 2987-2998, 1995.
310. Rampon C, Luppi PH, Fort P, Peyron C, and Jouvet M. Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain. Neuroscience 75: 737-755, 1996.
311. Rea R, Tijssen MA, Herd C, Frants RR, and Kullmann DM. Functional characterization of compound heterozygosity for GlyRα1 mutations in the startle disease hyperekplexia. Eur J Neurosci 16: 186-196, 2002.
312. Rees MI, Andrew M, Jawad S, and Owen MJ. Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the α1 subunit of the inhibitory glycine receptor. Hum Mol Genet 3: 2175-2179, 1994.
313. Rees MI, Harvey K, Ward H, White JH, Evans L, Duguid IC, Hsu CC, Coleman SL, Miller J, Baer K, Waldvogel HJ, Gibbon F, Smart TG, Owen MJ, Harvey RJ, and Snell RG. Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J Biol Chem 278: 24688-24696, 2003.
314. Rees MI, Lewis TM, Kwok JB, Mortier GR, Govaert P, Snell RG, Schofield PR, and Owen MJ. Hyperekplexia associated with compound heterozygote mutations in the β-subunit of the human inhibitory glycine receptor (GLRB). Hum Mol Genet 11: 853-860, 2002.
315. 1-subunit of the inhibitory glycine receptor in hyperekplexia. Hum Genet 109: 267-270, 2001.
316. 3 receptor pore revealed by substituted cysteine accessibility mutagenesis. J Biol Chem 276: 42035-42042, 2001.
317. Regan L. Protein design: novel metal-binding sites. Trends Biochem Sci 20: 280-285, 1995.
318. A receptor at sites on the N-terminal side of the middle of TM2. Neuroreport 9: 379-383, 1998.
319. Roos MH, Kwa MS, Veenstra JG, Kooyman FN, and Boersema JH. Molecular aspects of drug resistance in parasitic helminths. Pharmacol Ther 60: 331-336, 1993.
320. Rovira JC, Ballesta JJ, Vicente-Agullo F, Campos-Caro A, Criado M, Sala F, and Sala S. A residue in the middle of the M2-M3 loop of the β4 subunit specifically affects gating of neuronal nicotinic receptors. FEBS Lett 433: 89-92, 1998.
321. Rovira JC, Vicente-Agullo F, Campos-Caro A, Criado M, Sala F, Sala S, and Ballesta JJ. Gating of α3β4 neuronal nicotinic receptor can be controlled by the loop M2-M3 of both α3 and β4 subunits. Pflügers Arch 439: 86-92, 1999.
322. Ruiz-Gomez A, Morato E, Garcia-Calvo M, Valdivieso F, and Mayor F Jr. Localization of the strychnine binding site on the 48-kilodalton subunit of the glycine receptor. Biochemistry 29: 7033-7040, 1990.
323. Ruiz-Gomez A, Vaello ML, Valdivieso F, and Mayor F Jr. Phosphorylation of the 48-kDa subunit of the glycine receptor by protein kinase C. J Biol Chem 266: 559-566, 1991.
324. Rundstrom N, Schmieden V, Betz H, Bormann J, and Langosch D. Cyanotriphenylborate: subtype-specific blocker of glycine receptor chloride channels. Proc Natl Acad Sci USA 91: 8950-8954, 1994.
325. Russier M, Kopysova IL, Ankri N, Ferrand N, and Debanne D. GABA and glycine co-release optimizes functional inhibition in rat brainstem motoneurons in vitro. J Physiol 541: 123-137, 2002.
326. Ryan SG, Buckwalter MS, Lynch JW, Handford CA, Segura L, Shiang R, Wasmuth JJ, Camper SA, Schofield P, and O'Connell P. A missense mutation in the gene encoding the α1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nat Genet 7: 131-135, 1994.
327. Ryan SG, Dixon MJ, Nigro MA, Kelts KA, Markand ON, Terry JC, Shiang R, Wasmuth JJ, and O'Connell P. Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q. Am J Hum Genet 51: 1334-1343, 1992.
328. Sadtler S, Laube B, Lashub A, Nicke A, Betz H, and Schmalzing G. A basic cluster determines topology of the cytoplasmic M3-M4 loop of the glycine receptor α1 subunit. J Biol Chem 278: 16782-16790, 2003.
329. A- receptor subunits in the rat retina. J Comp Neurol 357: 1-14, 1995.
330. Sassoe-Pognetto M, Wassle H, and Grunert U. Glycinergic synapses in the rod pathway of the rat retina: cone bipolar cells express the α1 subunit of the glycine receptor. J Neurosci 14: 5131-5146, 1994.
331. Sato K, Zhang JH, Saika T, Sato M, Tada K, and Tohyama M. Localization of glycine receptor α1 subunit mRNA-containing neurons in the rat brain: an analysis using in situ hybridization histochemistry. Neuroscience 43: 381-395, 1991.
332. Sato Y, Son JH, and Meizel S. The mouse sperm glycine receptor/chloride channel: cellular localization and involvement in the acrosome reaction initiated by glycine. J Androl 21: 99-106, 2000.
333. - channel. Dev Biol 227: 211-218, 2000.
334. Saul B, Kuner T, Sobetzko D, Brune W, Hanefeld F, Meinck HM, and Becker CM. Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating. J Neurosci 19: 869-877, 1999.
335. Saul B, Schmieden V, Kling C, Mulhardt C, Gass P, Kuhse J, and Becker CM. Point mutation of glycine receptor α1 subunit in the spasmodic mouse affects agonist responses. FEBS Lett 350: 71-76, 1994.
336. Schmieden V and Betz H. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds. Mol Pharmacol 48: 919-927, 1995.
337. Schmieden V, Jezequel S, and Betz H. Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds. Mol Pharmacol 50: 1200-1206, 1996.
338. Schmieden V, Kuhse J, and Betz H. Mutation of glycine receptor subunit creates beta-alanine receptor responsive to GABA. Science 262: 256-258, 1993.
339. Schmieden V, Kuhse J, and Betz H. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition. Mol Pharmacol 56: 464-472, 1999.
340. 1 subunit is a determinant of gating in the glycine receptor. J Biol Chem 278: 34079-34083, 2003.
341. Shan Q, Haddrill JL, and Lynch JW. A single beta subunit M2 domain residue controls the picrotoxin sensitivity of αβ heteromeric glycine receptor chloride channels. J Neurochem 76: 1109-1120, 2001.
342. Shan Q, Haddrill JL, and Lynch JW. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem 276: 12556-12564, 2001.
343. A receptors. J Biol Chem 277: 44845-44853, 2002.
344. Shan Q, Nevin ST, Haddrill JL, and Lynch JW. Asymmetric contribution of α and β subunits to the activation of αβ heteromeric glycine receptors. J Neurochem 86: 498-507, 2003.
345. Shiang R, Ryan SG, Zhu YZ, Fielder TJ, Allen RJ, Fryer A, Yamashita S, O'Connell P, and Wasmuth JJ. Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol 38: 85-91, 1995.
346. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, and Wasmuth JJ. Mutations in the al subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5: 351-358, 1993.
347. Singer JH, Talley EM, Bayliss DA, and Berger AJ. Development of glycinergic synaptic transmission to rat brain stem motoneurons. J Neurophysiol 80: 2608-2620, 1998.
348. Sivilotti L and Nistri A. GABA receptor mechanisms in the central nervous system. Prog Neurobiol 36: 35-92, 1991.
349. Smart TG, Xie X, and Krishek BJ. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog Neurobiol 42: 393-341, 1994.
350. Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, Lodder H, van der Schors RC, van Elk R, Sorgedrager B, Brejc K, Sixma TK, and Geraerts WP. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411: 261-268, 2001.
351. Smith AJ, Owens S, and Forsythe ID. Characterisation of inhibitory and excitatory postsynaptic currents of the rat medial superior olive. J Physiol 529: 681-698, 2000.
352. Smith SM and McBurney RN. Caesium ions: a glycine-activated channel agonist in rat spinal cord neurones grown in cell culture. Br J Pharmacol 96: 940-948, 1989.
353. Spencer RH and Rees DC. The α-helix and the organization and gating of channels. Annu Rev Biophys Biomol Struct 31: 207-233, 2002.
354. 3 receptor ligand binding domain. J Biol Chem 275: 5620-5625, 2000.
355. Stein V and Nicoll RA. GABA generates excitement. Neuron 37: 375-378, 2003.
356. Steinbach JH, Bracamontes J, Yu L, Zhang P, and Covey DF. Subunit-specific action of an anticonvulsant thiobutyrolactone on recombinant glycine receptors involves a residue in the M2 membrane-spanning region. Mol Pharmacol 58: 11-17, 2000.
357. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol 145: 669-679, 2001.
358. Supplisson S and Chesnoy-Marchais D. Glycine receptor beta subunits play a critical role in potentiation of glycine responses by ICS-205,930. Mol Pharmacol 58: 763-770, 2000.
359. Suwa H, Saint-Amant L, Triller A, Drapeau P, and Legendre P. High-affinity zinc potentiation of inhibitory postsynaptic glycinergic currents in the zebrafish hindbrain. J Neurophysiol 85: 912-925, 2001.
360. Swope SL, Moss SI, Raymond LA, and Huganir RL. Regulation of ligand-gated ion channels by protein phosphorylation. Adv Second Messenger Phosphoprotein Res 33: 49-78, 1999.
361. Takahashi T, Momiyama A, Hirai K, Hishinuma F, and Akagi H. Functional correlation of fetal and adult forms of glycine receptors with developmental changes in inhibitory synaptic receptor channels. Neuron 9: 1155-1161, 1992.
362. Taleb O and Betz H. Expression of the human glycine receptor al subunit in Xenopus oocytes: apparent affinities of agonists increase at high receptor density. EMBO J 13: 1318-1324, 1994.
363. Tamamizu S, Todd AP, and McNamee MG. Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine. Cell Mol Neurobiol 15: 427-438, 1995,
364. Tao L and Ye JH. Protein kinase C modulation of ethanol inhibition of glycine-activated current in dissociated neurons of rat ventral tegmental area. J Pharmacol Exp Ther 300: 967-975, 2002.
365. Tapia JC and Aguayo LG. Changes in the properties of developing glycine receptors in cultured mouse spinal neurons. Synapse 28: 185-194, 1998.
366. Tapia JC, Aguilar LF, Sotomayor CP, and Aguayo LG. Ethanol affects the function of a neurotransmitter receptor protein without altering the membrane lipid phase. Eur J Pharmacol 354: 239-244, 1998.
367. Thio LL, Shanmugam A, Isenberg K, and Yamada K. Benzodiazepines block α2-containing inhibitory glycine receptors in embryonic mouse hippocampal neurons. J Neurophysiol 90: 89-99, 2003.
368. Tian N, Hwang TN, and Copenhagen DR. Analysis of excitatory and inhibitory spontaneous synaptic activity in mouse retinal ganglion cells. J Neurophysiol 80: 1327-1340, 1998.
369. Todd AJ, Watt C, Spike RC, and Sieghart W. Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord. J Neurosci 16: 974-982, 1996.
370. Triller A, Cluzeaud F, and Korn H. γ-Aminobutyric acid-containing terminals can be apposed to glycine receptors at central synapses. J Cell Biol 104: 947-956, 1987.
371. Triller A, Cluzeaud F, Pfeiffer F, Betz H, and Korn H. Distribution of glycine receptors at central synapses: an immunoelectron microscopy study. J Cell Biol 101: 683-688, 1985.
372. Tsutsui K, Ukena K, Usui M, Sakamoto H, and Takase M. Novel brain function: biosynthesis and actions of neurosteroids in neurons. Neurosci Res 36: 261-273, 2000.
373. Turecek R and Trussell LO. Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse. Nature 411: 587-590, 2001.
374. Twyman RE and MacDonald RL. Kinetic properties of the glycine receptor main- and sub-conductance states of mouse spinal cord neurones in culture. J Physiol 435: 303-331, 1991.
375. Umemiya M and Berger AJ. Presynaptic inhibition by serotonin of glycinergic inhibitory synaptic currents in the rat brain stem. J Neurophysiol 73: 1192-1201, 1995.
376. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 373: 37-43, 1995.
377. Unwin N, Miyazawa A, Li J, and Fujiyoshi Y. Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the a subunits. J Mol Biol 319: 1165-1176, 2002.
378. Vaello ML, Ruiz-Gomez A, Lerma J, and Mayor F Jr. Modulation of inhibitory glycine receptors by phosphorylation by protein kinase C and cAMP-dependent protein kinase. J Biol Chem 269: 2002-2008, 1994.
379. Vafa B, Lewis TM, Cunningham AM, Jacques P, Lynch JW, and Schofield PR. Identification of a new ligand binding domain in the al subunit of the inhibitory glycine receptor. J Neurochem 73: 2158-2166, 1999.
380. Valenzuela CF, Cardoso RA, Wick MJ, Weiner JL, Dunwiddie TV, and Harris RA. Effects of ethanol on recombinant glycine receptors expressed in mammalian cell lines. Alcohol Clin Exp Res 22: 1132-1136, 1998.
381. Vandenberg RJ, French CR, Barry PH, Shine J, and Schofield PR. Antagonism of ligand-gated ion channel receptors: two domains of the glycine receptor a subunit form the strychnine-binding site. Proc Natl Acad Sci USA 89: 1765-1769, 1992.
382. Vandenberg RJ, Handford CA, and Schofield PR. Distinct agonist-and antagonist-binding sites on the glycine receptor. Neuron 9: 491-496, 1992.
383. Van den Pol AN and Gorcs T. Glycine and glycine receptor immunoreactivity in brain and spinal cord. J Neurosci 8: 472-492, 1988.
384. Vergouwe MN, Tijssen MA, Peters AC, Wielaard R, and Frants RR. Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations. Ann Neurol 46: 634-638, 1999.
385. Vogt K, Mellor J, Tong G, and Nicoll R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron 26: 187-196, 2000.
386. Von Wegerer J, Becker K, Glockenhammer D, Becker CM, Zeilhofer HU, and Swandulla D. Spinal inhibitory synaptic transmission in the glycine receptor mouse mutant spastic. Neurosci Lett 345: 45-48, 2003,
387. Wang F and Imoto K. Pore size and negative charge as structural determinants of permeability in the Torpedo nicotinic acetylcholine receptor channel. Proc R Soc Lond B Biol Sci 250: 11-17, 1992.
388. Wang HL, Milone M, Ohno K, Shen XM, Tsujino A, Batocchi AP, Tonali P, Brengman J, Engel AG, and Sine SM. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci 2: 226-233, 1999.
389. Wang TL, Hackam AS, Guggino WB, and Cutting GR. A single amino acid in γ-aminobutyric acid ρ1 receptors affects competitive and noncompetitive components of picrotoxin inhibition. Proc Natl Acad Sci USA 92: 11751-11755, 1995.
390. Wassle H and Boycott BB. Functional architecture of the mammalian retina. Physiol Rev 71: 447-480, 1991.
391. Wassle H, Koulen P, Brandstatter JH, Fletcher EL, and Becker CM. Glycine and GABA receptors in the mammalian retina. Vision Res 38: 1411-1430, 1998.
392. Watanabe E and Akagi H. Distribution patterns of mRNAs encoding glycine receptor channels in the developing rat spinal cord. Neurosci Res 23: 377-382, 1995.
393. Weaver CD, Partridge JG, Yao TL, Moates JM, Magnuson MA, and Verdoorn TA. Activation of glycine and glutamate receptors increases intracellular calcium in cells derived from the endocrine pancreas. Mol Pharmacol 54: 639-646, 1998.
394. A receptors. J Pharmacol Exp Ther 284: 95-102, 1998.
395. Werman R, Davidoff RA, and Aprison MH. Inhibition of motoneurones by iontophoresis of glycine. Nature 214: 681-683, 1967.
396. Werman R, Davidoff RA, and Aprison MH. Inhibition of glycine on spinal neurons in the cat. J Neurophysiol 31: 81-95, 1968.
397. A responses in stably transfected cells. J Neurochem 66: 1318-1321, 1996.
398. Wheeler M, Stachlewitz RF, Yamashina S, Ikejima K, Morrow AL, and Thurman RG. Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production. FASEB J 14: 476-484, 2000.
399. Wick MJ, Mihic SJ, Ueno S, Mascia MP, Trudell JR, Brozowski SJ, Ye Q, Harrison NL, and Harris RA. Mutations of γ-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci USA 95: 6504-6509, 1998.
400. Williams DB and Akabas MH. γ-Aminobutyric acid increases the water accessibility of M3 membrane-spanning segment residues in γ-aminobutyric acid type A receptors. Biophys J 77: 2563-2574, 1999.
401. A receptors. Neuropharmacology 41: 539-545, 2001.
402. A receptor states at potentiating and activating concentrations. J Neurosci 22: 7417-7424, 2002.
403. Wilson G and Karlin A. Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine- accessibility method. Proc Natl Acad Sci USA 98: 1241-1248, 2001.
404. Wilson GG and Karlin A. The location of the gate in the acetylcholine receptor channel. Neuron 20: 1269-1281, 1998.
405. Wilson GG, Pascual JM, Brooijmans N, Murray D, and Karlin A. The intrinsic electrostatic potential and the intermediate ring of charge in the acetylcholine receptor channel. J Gen Physiol 115: 93-106, 2000.
406. Wotring VE, Miller TS, and Weiss DS. Mutations at the GABA receptor selectivity filter: a possible role for effective charges. J Physiol 548: 527-540, 2003.
407. Wu FS, Chen SC, and Tsai JJ. Competitive inhibition of the glycine-induced current by pregnenolone sulfate in cultured chick spinal cord neurons. Brain Res 750: 318-320, 1997.
408. Wu FS, Gibbs TT, and Farb DH. Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol 37: 597-602, 1990.
409. A receptor α1 subunit. J Gen Physiol 107: 195-205, 1996.
410. A receptor channel-lining residues probed in cysteine mutants. Biophys J 69: 1858-1867, 1995.
411. Xu TL, Dong XP, and Wang DS. N-methyl-D-aspartate enhancement of the glycine response in the rat sacral dorsal commissural neurons. Eur J Neurosci 12: 1647-1653, 2000.
412. 2+-permeable AMPA receptors in rat spinal neurones. J Physiol 514: 701-711, 1999.
413. A counterpart. J Mol Biol 312: 915-920, 2001.
414. Yadid G, Goldstein DS, Pacak K, Kopin IJ, and Golomb E. Functional α3-glycine receptors in rat adrenal. Eur J Pharmacol 288: 399-401, 1995.
415. Yadid G, Maor G, Youdim MB, Silberman M, and Zinder O. Autoradiographic localization of strychnine-sensitive glycine receptor in bovine adrenal medulla. Neurochem Res 18: 1051-1055, 1993.
416. Yadid G, Youdim MB, and Zinder O. High-affinity strychnine binding to adrenal medulla chromaffin cell membranes. Eur J Pharmacol 175: 365-366, 1990.
417. Yadid G, Youdim MB, and Zinder O. Preferential release of epinephrine by glycine from adrenal chromaffin cells. Eur J Pharmacol 221: 389-391, 1992.
418. Yamakura T, Bertaccini E, Trudell JR, and Harris RA. Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol 41: 23-51, 2001.
419. Yamakura T and Harris RA. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93: 1095-1101, 2000.
420. Yamakura T, Mihic SJ, and Harris RA. Amino acid volume and hydropathy of a transmembrane site determine glycine and anesthetic sensitivity of glycine receptors. J Biol Chem 274: 23006-23012, 1999.
421. Yamashita M, Ueno T, Akaike N, and Ikemoto Y. Modulation of miniature inhibitory postsynaptic currents by isoflurane in rat dissociated neurons with glycinergic synaptic boutons. Eur J Pharmacol 431: 269-276, 2001.
422. Ye JH, Tao L, Ren J, Schaefer R, Krnjevic K, Liu PL, Schiller DA, and McArdle JJ. Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area. J Pharmacol Exp Ther 296: 77-83, 2001.
423. Ye JH, Tao L, Zhu L, Krnjevic K, and McArdle JJ. Ethanol inhibition of glycine-activated responses in neurons of ventral tegmental area of neonatal rats. J Neurophysiol 86: 2426-2434, 2001.
424. Ye Q, Koltchine VV, Mihic SJ, Mascia MP, Wick MJ, Finn SE, Harrison NL, and Harris RA. Enhancement of glycine receptor function by ethanol is inversely correlated with molecular volume at position α267. J Biol Chem 273: 3314-3319, 1998.
425. Yevenes GE, Peoples RW, Tapia JC, Parodi J, Soto X, Olate J, and Aguayo LG. Modulation of glycine-activated ion channel function by G-protein βγ subunits. Nat Neurosci 6: 819-824, 2003.
426. Yoon KW, Wotring VE, and Fuse T. Multiple picrotoxinin effect on glycine channels in rat hippocampal neurons. Neuroscience 87: 807-815, 1998.
427. Young AB and Snyder SH. Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci USA 70: 2832-2836, 1973.
428. Young AB and Snyder SH. The glycine synaptic receptor: evidence that strychnine binding is associated with the ionic conductance mechanism. Proc Natl Acad Sci USA 71: 4002-4005, 1974.
429. Young AB, Zukin SR, and Snyder SH. Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action. Proc Natl Acad Sci USA 71: 2246-2250, 1974.
430. Zacharias N and Dougherty DA. Cation-π interactions in ligand recognition and catalysis. Trends Pharmacol Sci 23: 281-287, 2002.
431. 3H]strychnine. J Neurosci 1: 532-547, 1981.
432. Zhang H and Karlin A. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the beta-subunit. Biochemistry 36: 15856-15864, 1997.
433. Zhang HG, French-Constant RH, and Jackson MB. A unique amino acid of the Drosophila GABA receptor with influence on drug sensitivity by two mechanisms. J Physiol 479: 65-75, 1994.
434. Zhong W, Gallivan JP, Zhang Y, Li L, Lester HA, and Dougherty DA. From ab initio quantum mechanics to molecular neurobiology: a cation-π binding site in the nicotinic receptor. Proc Natl Acad Sci USA 95: 12088-12093, 1998.
435. Zhorov BS and Bregestovski PD. Chloride channels of glycine and GABA receptors with blockers: Monte Carlo minimization and structure-activity relationships. Biophys J 78: 1786-1803, 2000.
436. Zhou L, Chillag KL, and Nigro MA. Hyperekplexia: a treatable neurogenetic disease. Brain Dev 24: 669-674, 2002.
437. Zhu L, Jiang ZL, Krnjevic K, Wang FS, and Ye JH. Genistein directly blocks glycine receptors of rat neurons freshly isolated from the ventral tegmental area. Neuropharmacology 45: 270-280, 2003.
438. Zhu L, Krnjevic K, Jiang Z, McArdle JJ, and Ye JH. Ethanol suppresses fast potentiation of glycine currents by glutamate. J Pharmacol Exp Ther 302: 1193-1200, 2002.